125742 S44 M1 response 10aug2021
Document text
COVID -19 Vaccine (BNT162, PF -07302048) BLA 125742/0 Response to 10 Aug 2021 FDA IR – Testing Related PFIZER CONFIDENTIAL Page 1QUERY 1 Please provide the established and poly dispersity index limits for the control lot of PF -07302048 -DP-RM for the test of “Size and poly dispersity Index Measurement in mRNA LNP Samples b y Dynam ic Light Scattering” for drug product. RESPONSE 1 Table 1provides the established and maximum poly dispers ity index (PDI) for control lot PF -07302048 -DP-RM. Table 1. Established Acceptable and PDI Ranges for PF-07302048 -DP-RM (Lot # EE8493) Control Criterion Upper Limit Lower Limit Literature References None SUPPORTING DOCUMENTATION New or Replaced Supporting Documentation None Previously submitted supporting documentation None 090177e197c95a16\Approved\Approved On: 11-Aug-2021 15:59 (GMT) (b) (4) (b) (4) (b) (4) (b) (4) FDA-CBER-2021-5683-1149574